Healthcare Plans Drive Antisense And RNAi Therapeutics Marke...| MENAFN.COM

Friday, 28 January 2022 08:32 GMT

Healthcare Plans Drive Antisense And RNAi Therapeutics Market Growth


(MENAFN- EIN Presswire)

Antisense And RNAi Therapeutics Market 2021 – Opportunities And Strategies – Global Forecast To 2030

The Business Research Company's Antisense And RNAi Therapeutics Market 2021 – Opportunities And Strategies – Global Forecast To 2030

LONDON, GREATER LONDON, UK, November 29, 2021 /EINPresswire.com / -- Access to healthcare services is expected to improve in developing countries, thus supporting the antisense and RNAi therapeutics market. Effective implementation of government health plans is the core reason for the improvement in healthcare access in many developing regions such as India, China and many Latin American countries. Many countries such as Russia and Brazil are focusing on improving their healthcare capabilities which will help drive the antisense and RNAi therapeutics market.

TBRC's holiday sale has begun with discounts on ALL market research reports! Grab your deal now.

The global antisense and RNAi therapeutics market size reached a value of nearly $3.67 billion in 2020, having increased at a compound annual growth rate (CAGR) of 38.2% since 2017. The market is expected to grow from $3.67 billion in 2020 to $5.66 billion in 2025 at a rate of 9.0%. The growth is mainly due to the growing demand for antisense and RNAi therapeutics due to COVID-19 which is expected to drive the demand for antisense and RNAi therapeutics. The market is expected to grow to $8.26 billion in in 2030 at a CAGR of 7.9%.

Read More On The Global Antisense And RNAi Therapeutics Market Report:

RNAi therapeutics are being widely used to provide effective treatment for many complex orphan diseases such as acute hepatic porphyria (AHP) and hereditary transthyretin amyloidosis that have limited treatment options. RNAi therapeutic companies are increasingly opting to produce drugs for orphan diseases as people suffering from orphan diseases are often more willing to tolerate drugs with side effects. People suffering from orphan diseases also visit doctors regularly, thus find it acceptable to opt for drugs that have a more involved delivery route. The disease is caused by mutations in the gene that can cause causes a loss of sensation in the lower limbs, feet, and hands. The disease may also cause disturbances in blood pressure, heart rate, and digestion.

Major players covered in the global antisense and RNAi therapeutics industry are Biogen Inc., Ionis Pharmaceuticals, Inc., Alnylam Pharmaceuticals, Inc., Arrowhead Pharmaceuticals, Inc., Moderna, Inc.

Western Europe was the largest region in the global antisense and RNAi therapeutics market, accounting for 52.0% of the total in 2020. It was followed by the North America, Asia Pacific, and then the other regions. Going forward, the fastest-growing regions in the antisense and RNAi therapeutics market will be Middle East and Africa, where growth will be at CAGRs of 22.5% and 17.9% respectively. These will be followed by Asia Pacific and South America, where the markets are expected to register CAGRs of 15.8% and 15.0% respectively.

TBRC's global antisense & RNAi therapeutics market report is segmented by technology into RNA interference, antisense RNA, by route of administration into pulmonary delivery, intravenous injections, intra-dermal injections, intraperitoneal injections, topical delivery, other delivery methods, by indication into oncology, cardiovascular diseases (CVDs), respiratory disorders, neurological disorders, infectious diseases, other.

Antisense And RNAi Therapeutics Market 2021 - By Technology (RNA Interference, Antisense RNA), By Route Of Administration (Intravenous injections, Intra Dermal injunctions, Other delivery methods), By Indication (Oncology, Cardiovascular device, Respiratory disorders, Neurological disorders, Infectious disease), And By Region, Opportunities And Strategies – Global Forecast To 2030 is one of a series of new reports from The Business Research Company that provides antisense and RNAi therapeutics market overview, forecast antisense and RNAi therapeutics market size and growth for the whole market, antisense and RNAi therapeutics market segments, and geographies, antisense and RNAi therapeutics market trends, antisense and RNAi therapeutics market drivers, restraints, leading competitors' revenues, profiles, and market shares.

Request For A Sample Of The Global Antisense And RNAi Therapeutics Market Report:

Here Is A List Of Similar Reports By The Business Research Company:
Nucleic Acid Based Gene Therapy Global Market Report 2021 - By Technology (Anti-Sense And Anti-Gene, Short Inhibitory Sequences, Gene Transfer Therapy, Nucleoside Analogs, Ribozymes, Aptamers), By Application (Oncology, Muscular Dystrophy/ Muscular Disorders, Rare Diseases), By End User (Hospitals And Clinics, Academic And Research Institutes), COVID-19 Growth And Change

Oligonucleotide Therapy Global Market Report 2021 - By Type (Antisense Oligonucleotide, Aptamer), By Application (Infectious Diseases, Oncology, Neurodegenerative Disorders, Cardiovascular Diseases, Kidney Diseases), By End User (Hospitals, Research Institutes), COVID-19 Growth And Change

Anti-Hypertensive Drugs Global Market Report 2021 - By Therapeutics (Diuretics, Angiotensin Receptor Blockers (ARBs), Angiotensin Converting Enzyme (ACE) Inhibitors, Beta Blockers, Alpha Blockers, Calcium Channel Blockers, Renin Inhibitors, Vasodilators), By Disease Source (Primary Hypertension, Secondary Hypertension), By End Users (Hospitals, Clinics, Homecare), COVID-19 Impact And Recovery

Interested to know more about The Business Research Company?

The Business Research Company is a market research and intelligence firm that excels in company, market, and consumer research. It has over 200 research professionals at its offices in India, the UK and the US, as well a network of trained researchers globally. It has specialist consultants in a wide range of industries including manufacturing, healthcare, financial services and technology.

Read more about us at

Or get a quick glimpse of our services here:

Call us now for personal assistance with your purchase:
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293

The Business Research Company
Email:
Follow us on LinkedIn:
Follow us on Twitter:
Check out our Blog:

Oliver Guirdham
The Business Research Company
+44 20 7193 0708

Visit us on social media:
Facebook
Twitter
LinkedIn

MENAFN29112021003118003196ID1103270881


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.